Epidemiology of arterial hypertension in renal transplant patients: Changes over the last decade

Nephrology Dialysis Transplantation

Volumn 19, Issue SUPPL. 3, 2004, Pages

  Campistol, Josep M ^a   Romero, Rafael ^b   Paul, Javier ^c   Gutiérrez Dalmu, Alex ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Angiotensin converting enzyme inhibitors; Arterial hypertension; Cardiovascular mortality; Cylosporine; Graft survival

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CREATININE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; AGE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

FEMALE; GRAFT SURVIVAL; HUMANS; HYPERTENSION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RISK FACTORS; SPAIN; TIME FACTORS;

EID: 3242716024     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh1018     Document Type: Article

References (16)

1. Zhang R, Leslie B, Boudreaux JP, Frey D, Reisin E. Hypertension after kidney transplantation: impact, pathogenesis and therapy. Am J Med Sci 2003; 325: 202-208
2. Opelz G, Wujciak T, Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int 1998; 53: 217-222
3. Kendrick E. Cardiovascular disease and the renal transplant recipient. Am J Kidney Dis 2001; 38 [Suppl 6]: S36-S43
4. Kasiske BL. Cardiovascular disease after renal transplantation. Semin Nephrol 2000; 20: 176-187
5. Tylicki L, Habicht A, Watschinger B, Horl WH. Treatment of hypertension in renal transplant recipients. Curr Opin Urol 2003; 13: 91-98
6. Serón D, Arias M, Campistol JM, Morales JM for the Spanish Chronic Allograft Nephropathy Study Group. Late renal allograft failure between 1990-1998 in Spain: a changing scenario. Transplantation 2003; 76: 1588-1594
7. Browne BJ, Holt CO, Emovon OE. Delayed graft function may not adversely affect short-term renal allograft outcome. Clin Transplant 2003;17 [Suppl 9]: 35-38
8. Curtis JJ. Hypertensinogenic mechanism of the calcineurin inhibitors. Curr Hypertens Rep 2002; 4: 377-380
9. Lassila M. Interaction of cyclosporine A and the reninangiotensin system; new perspectives. Curr Drug Metab 2002; 3: 61-71
10. Kusaka M, Mackenzie HS, Ziai F, Hancock WW, Tilney NL. Recipient hypertension potentiates chronic functional and structural injury of rat renal allografts. Transplantation 2002; 74: 307-314
11. Hariharan S. Long-term kidney transplant survival. Am J Kidney Dis 2001; 38 [Suppl 6]: S44-S50
12. Hausberg M, Kosch M, Hohage H et al. Antihypertensive treatment in renal transplant patients - is there a role for ACE inhibitors? Ann Transplant 2001; 6: 31-37
13. Baroletti SA, Gabardi S, Magee CC, Milford EL. Calcium channel blockers as the treatment of choice for hypertension in renal transplant recipients: fact or fiction. Pharmacotherapy 2003; 23: 788-801
14. Cheng CH, Hsieh CL, Shu KH, Chen YL, Chen HC. Effect of calcium channel antagonist diltiazem and calcium ionophore A23187 on cyclosporine A-induced apoptosis of renal tubular cells. FEBS Lett 2002; 516: 191-196
15. del Castillo D, Campistol JM, Guirado L et al. Efficacy and safety of losartan in the treatment of hypertension in renal transplant recipients. Kidney Int Suppl 1998; 68: S135-S139
16. Inigo P, Campistol JM, Lario S et al. Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta (1) plasma levels in a crossover trial in renal transplant recipients. J Am Soc Nephrol 2001; 12: 822-827